Full data view for gene GCDH

Variant classification: please note that where there are several records of the same variant, classification of that variant
may differ between records depending on the reporting publication or the submitter's opinion. For the curator’s opinion on
the classification, please view the SUMMARY record or the concluded functional effect (value in column Effect after the /).
Information The variants shown are described using the NM_000159.3 transcript reference sequence.

8 entries on 1 page. Showing entries 1 - 8.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/+ 4 c.262C>T r.(?) p.(Arg88Cys) Both (homozygous) - pathogenic (recessive) g.13002779C>T g.12891965C>T - - GCDH_000019 - PubMed: Külkens 2005, PubMed: Boy 2017, PubMed: Harting 2009 - - Germline/De novo (untested) - 1 - - - DNA ? - - GA1 15985591-Patient 2 PubMed: Külkens 2005, PubMed: Boy 2017, PubMed: Harting 2009 The same patient is described later by Harting 2009 (Pat. 12) and Boy 2017 (p2). Geographic and ethnic origin is displayed here according to Külkens and Harting. Late-onset GA-1; A few months after begin of therapy full recovery from neurologic disease, increased tolerance to physical exercise and continuation of professional career; Family history: several different neurologic diseases M no Austria white - - - - 1 Katrin Hinderhofer
+/+ 4 c.262C>T r.(?) p.(Arg88Cys) Both (homozygous) - pathogenic (recessive) g.13002779C>T g.12891965C>T - - GCDH_000019 - PubMed: Busquets 2000, PubMed: Schmiesing 2017 - - Germline/De novo (untested) - 1 - - - DNA SEQ, SSCA - - GA1 - PubMed: Busquets 2000, PubMed: Schmiesing 2017 Information on GCDH activity: Schmiesing 2017 - no Italy - - - - - 1 Katrin Hinderhofer
+/+ 4 c.262C>T r.(?) p.(Arg88Cys) Unknown - pathogenic (recessive) g.13002779C>T g.12891965C>T - - GCDH_000019 - PubMed: Schwartz 1998, PubMed: Schmiesing 2017 - - Germline/De novo (untested) - - - - - RNA PCRdig, SEQ, SSCA - - GA1 - PubMed: Schwartz 1998, PubMed: Schmiesing 2017 Information on phenotype: see Schmiesing 2017 ? ? Austria - - - - - 1 Svenja Wagner
+/+ 4 c.262C>T r.(?) p.(Arg88Cys) Unknown - pathogenic (recessive) g.13002779C>T g.12891965C>T - - GCDH_000019 - PubMed: Heringer 2010, PubMed: Boy 2017, PubMed: Boy 2018 - - Germline/De novo (untested) - - - - - ? ? - - GA1 21031586-Case 1 (PID 43) PubMed: Heringer 2010, PubMed: Boy 2017, PubMed: Boy 2018 This patient is later described again by Boy 2017 (c3) and Boy 2018 (PID2); Increased glutarylcarnitine concentration in newborn screening but normal results for GA and 3-OH-GA (urine) in semiquantative analysis --> Diagnosis missed at birth and only confirmed 04m later by quantitative GC/MS analysis! F ? Germany Swiss - - - - 1 Isabelle Rinke
+/+ 4 c.262C>T r.(?) p.(Arg88Cys) Unknown - pathogenic (recessive) g.13002779C>T g.12891965C>T - - GCDH_000019 - PubMed: Christensen 2004, PubMed: Schmiesing 2017 - - Germline/De novo (untested) - - - - - ? ? - - GA1 28062662-Line4 (table 1) PubMed: Christensen 2004, PubMed: Schmiesing 2017 - ? ? - - - - - - 1 Isabelle Rinke
+/+ 4 c.262C>T r.(?) p.(Arg88Cys) Unknown - pathogenic (recessive) g.13002779C>T g.12891965C>T - - GCDH_000019 - PubMed: Christensen 2004, PubMed: Schmiesing 2017 - - Germline/De novo (untested) - - - - - ? ? - - GA1 28062662-Line5 (table 1) PubMed: Christensen 2004, PubMed: Schmiesing 2017 - ? ? - - - - - - 1 Isabelle Rinke
+/+ 4 c.262C>T r.(?) p.(Arg88Cys) Unknown ACMG pathogenic g.13002779C>T g.12891965C>T - - GCDH_000019 ACMG/ACGS: PS4_Moderate, PM3_Strong, PP4, PP3_Strong, PS3, PM2_Supporting (December 2023) - - - SUMMARY record - - - - - - - - - - - - - - - - - - - - - - -
+/+ 4 c.262C>T r.(?) p.(Arg88Cys) Unknown - pathogenic (recessive) g.13002779C>T g.12891965C>T - - GCDH_000019 - PubMed: Sitta 2021 - - Germline/De novo (untested) - 1/48 (alleles) - - - DNA PCR, SEQ dried blood spots - GA1 Pat10 PubMed: Sitta 2021 - M no Brazil - - - - all patients diagnosed in the authors laboratory were immediately submitted to the available treatment based on protein (lysine) restricted diets and L-carnitine supplementation 1 Sabrina Oeser
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.